NSAIDs double risk of bleeding in patients taking antithrombotics after myocardial infarction, study findsBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1043 (Published 25 February 2015) Cite this as: BMJ 2015;350:h1043
- Susan Mayor
Non-steroidal anti-inflammatory drugs (NSAIDs) more than double the risk of bleeding and also increase the risk of cardiovascular events among patients taking antithrombotic drugs after a myocardial infarction, even after short term treatment with NSAIDs, show results from a Danish study reported in JAMA.1
Guidelines recommend that dual antithrombotic therapy (aspirin and clopidogrel) should be prescribed to all patients who have a myocardial infarction for up to 12 months after the event, followed by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial